参考文献/References:
[1] 段桂珍,王磊,徐辉.曲美他嗪对慢性心力衰竭患者血浆脑钠肽及心功能的影响[J].新乡医学院学报,2014,31(8):649-651.
[2] 于君.心脏再同步化治疗无反应原因分析[J].医学综述,2014,20(20):3754-3756,封3.
[3] 杨震,于欣,贾绍斌,等.心脏再同步化治疗对失同步化缺血性心力衰竭心肌内向整流钾电流的影响[J].实用医学杂志,2013,29(5):721-723.
[4] 涂荣会,安维维,钟国强,等.心脏再同步化治疗对慢性心力衰竭患者死亡率及死亡模式的影响[J].中国老年学杂志,2014,34(13):3602-3607.
[5] WANG J,SU Y,BAI J,et al.Elevated pulmonary artery pressure predicts poor outcome after cardiac resynchronization therapy[J].J Interv Card Electrophysiol,2014,40(2):171-178.
[6] 刘西平,秦瑶,郝星,等.心脏再同步治疗慢性心力衰竭的临床效果及无反应原因的分析[J].重庆医学,2013,42(2):209-211.
[7] CHATTERJEE N A,UPADHYAY G A,SINGAL G,et al.Pre-capillary pulmonary hypertension and right ventricular dilation predict clinical outcome in cardiac resynchronization therapy[J].JACC Heart Fail,2014,2(3):230-237.
[8] WANG D,HAN Y,ZANG H,et al.Prognostic effects of pulmonary hypertension in patients undergoing cardiac resynchronization therapy[J].J Thorac Dis,2010,2(2):71-75.
[9] PRAUS R,HAMAN L,TAUCHMAN M,et al.Echocardiographic changes after cardiac resynchronisation therapy[J].Kardiol Pol,2012,70(12):1250-1257.
[10] STHLBERG M,HILPISCH K,REITERS P,et al.Haemodynamic effects of different basic heart rates in ambulatory heart failure patients treated with cardiac resynchronization therapy[J].Europace,2013,15(8):1182-1190.
[11] BRAMBATTI M,GUERRA F,MATASSINI M V,et al.Cardiac resynchronization therapy improves ejection fraction and cardiac remodelling regardless of patients′ age[J].Europace,2013,15(5):704-710.
[12] CHATURVEDI V.Current research on the relevance of electrocardiography in cardiac resynchronization therapy[J].Indian Pacing Electrophysiol J,2015,15(2):145-147.